GlassScriptPhysician profile
Changtai Tian
NPI 1871171561
$1,587.61
in general payments reported to CMS, 2019-2025
16 companies · $1,351 in 2025
The $1,351 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $237 · 2025: $1,351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,205 · Education: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,204.68 |
| Education | $382.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $323.84 | 2025 | Rybrevant, Carvykti, Erleada |
| Caris Mpi, INC. | $224.47 | 2025 | Mi Cancer Seek |
| Sobi, INC | $174.50 | 2024-2025 | |
| Exelixis INC. | $117.88 | 2025 | Cabometyx |
| Abbvie INC. | $99.99 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $89.02 | 2024-2025 | Enhertu |
| Seagen INC. | $83.99 | 2025 | |
| Genentech USA, INC. | $83.62 | 2025 | Tecentriq, Itovebi, Venclexta |
| Pfizer INC. | $79.08 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $75.96 | 2025 | Iclusig, Fruzaqla |
| Bayer Healthcare Pharmaceuticals INC. | $53.98 | 2025 | |
| Puma Biotechnology, INC. | $50.95 | 2025 | |
| Tersera Therapeutics LLC | $40.17 | 2024-2025 | Zoladex |
| Springworks Therapeutics, INC. | $33.10 | 2024 | Ogsiveo |
| Merck Sharp & Dohme LLC | $29.92 | 2024-2025 | Keytruda, Lynparza, Keytruda Qlex |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $27.14 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Changtai Tian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.